A study of 231 patients with osteoporosis treated with either alendronate or risedronate showed that undercarboxylated osteocalcin (ucOC) was significantly higher in patients who sustained an incident fracture despite bisphosphonate [16]. The gene discussed is BGLAP; the disease is osteoporosis.